Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 9Urinary Bladder Neoplasms 2Male Urogenital Diseases 2Precancerous Conditions 1Neoplasms 1Eye Diseases 1Colorectal Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1

Interventions

padeliporfin 5Lycopene 3pembrolizumab 2darolutamide 2Vitamin E 2Tea 2Selenium 2Cholecalciferol 2relatlimab 1palladium-bacteriopheophorbide 1olaparib 1gedatolisib 1enfortumab vedotin 1Therapeutics 1Sugars 1Radiation Dose Hypofractionation 1Pluvicto 1Nivolumab 1Mitomycin 1Intraoperative Neurophysiological Monitoring 1Gemcitabine 1Fluorouracil 1Cisplatin 1CP protocol 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Male Urogenital Diseases × Vitamin E × Genitourinary × Clear all
NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡